These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 27902472)
61. Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell. Shin GC; Ahn SH; Choi HS; Lim KH; Choi DY; Kim KP; Kim KH Biochim Biophys Acta; 2013 Oct; 1832(10):1569-81. PubMed ID: 23644164 [TBL] [Abstract][Full Text] [Related]
62. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. Kew MC J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526 [TBL] [Abstract][Full Text] [Related]
63. Hepatitis B virus X gene differentially modulates cell cycle progression and apoptotic protein expression in hepatocyte versus hepatoma cell lines. Yang CH; Cho M J Viral Hepat; 2013 Jan; 20(1):50-8. PubMed ID: 23231084 [TBL] [Abstract][Full Text] [Related]
64. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings. Kang-Park S; Lee JH; Shin JH; Lee YI Biochem Biophys Res Commun; 2001 May; 283(2):303-7. PubMed ID: 11327698 [TBL] [Abstract][Full Text] [Related]
65. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077 [TBL] [Abstract][Full Text] [Related]
66. Reduced RKIP Expression is Associated With Breast Neoplastic Progression and is Correlated With Poor Outcomes and Aberrant Methylation in Breast Carcinoma. Kim GE; Kim NI; Lee JS; Park MH; Yoon JH Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):467-474. PubMed ID: 26894644 [TBL] [Abstract][Full Text] [Related]
67. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Hildt E; Hofschneider PH Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012 [TBL] [Abstract][Full Text] [Related]
68. cis-Acting elements and trans-acting factors in the transcriptional regulation of raf kinase inhibitory protein expression. Zhang B; Wang O; Qin J; Liu S; Sun S; Liu H; Kuang J; Jiang G; Zhang W PLoS One; 2013; 8(12):e83097. PubMed ID: 24386147 [TBL] [Abstract][Full Text] [Related]
69. Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Doyle B; Hagan S; Al-Mulla F; Scott L; Harden S; Paul J; Mulcahy H; Murray GI; Sheahan K; O'Sullivan J; Kolch W Histopathology; 2013 Feb; 62(3):505-10. PubMed ID: 23460950 [TBL] [Abstract][Full Text] [Related]
70. [Expression and significance of Raf kinase inhibitory protein in lung cancer]. Yang D; Qi Z Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):597-601. PubMed ID: 23075684 [TBL] [Abstract][Full Text] [Related]
72. [The expression and significance of RKIP in lung squamous cell carcinoma tissues]. Xu H; Wang X; Shen W; Wang L; Shen G; Chen M; Zhou L Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):194-8. PubMed ID: 21426659 [TBL] [Abstract][Full Text] [Related]
73. Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma. Shvartsur A; Givechian KB; Garban H; Bonavida B J Exp Clin Cancer Res; 2017 May; 36(1):62. PubMed ID: 28476134 [TBL] [Abstract][Full Text] [Related]
74. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Beach S; Tang H; Park S; Dhillon AS; Keller ET; Kolch W; Yeung KC Oncogene; 2008 Apr; 27(15):2243-8. PubMed ID: 17952120 [TBL] [Abstract][Full Text] [Related]
75. Clinical significance of RKIP mRNA expression in non-small cell lung cancer. Wang Q; Wu X; Wu T; Li GM; Shi Y Tumour Biol; 2014 May; 35(5):4377-80. PubMed ID: 24420151 [TBL] [Abstract][Full Text] [Related]
76. RKIP expression of liver and kidney after arsenic exposure. Tsao DA; Tseng WC; Chang HR Environ Toxicol; 2017 Mar; 32(3):1079-1082. PubMed ID: 27255443 [TBL] [Abstract][Full Text] [Related]
77. TROY interacts with RKIP to promote glioma development. Liu X; Bao Y; Meng W; Yang P; An Y; Ma J; Tang Y; Liu Z; Lu Y; Zhou J; Zhang Y; Feng J; Gao X; Su Z; Pu Y; He C Oncogene; 2019 Feb; 38(9):1544-1559. PubMed ID: 30337686 [TBL] [Abstract][Full Text] [Related]
78. Trans-activation by hepatitis B virus X protein is mediated via a tumour promoter pathway. Kekulé AS; Lauer U; Weiss L; Hofschneider PH; Koshy R Arch Virol Suppl; 1992; 4():63-4. PubMed ID: 1450727 [TBL] [Abstract][Full Text] [Related]
79. [Influence of electromagnetic radiation on raf kinase inhibitor protein and its related proteins of hippocampus]. Zuo HY; Wang DW; Peng RY; Wang SM; Gao YB; Xu XP; Ma JJ Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Sep; 26(9):533-7. PubMed ID: 19309582 [TBL] [Abstract][Full Text] [Related]
80. Promoter methylation of Raf kinase inhibitory protein: A significant prognostic indicator for patients with gastric adenocarcinoma. Li DX; Cai HY; Wang X; Feng YL; Cai SW Exp Ther Med; 2014 Sep; 8(3):844-850. PubMed ID: 25120612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]